story of the week
First-Line T-DM1 for Patients With HER2+ Advanced Breast Cancer Who Are Unsuitable for Taxane-Based Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results From MARIANNE
Cancer 2019 Jul 18;[EPub Ahead of Print], EA Perez, C Barrios, W Eiermann, M Toi, YH Im, P Conte, M Martin, T Pienkowski, XB Pivot, HA Burris, JA Petersen, S De Haas, S Hoersch, M Patre, PA EllisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.